Original Article

You have full text access to this OnlineOpen article

A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices

  1. R Jalan,
  2. E H Forrest,
  3. A J Stanley,
  4. D N Redhead,
  5. J Forbes,
  6. J F Dillon,
  7. A J MacGilchrist,
  8. N D Finlayson,
  9. P C Hayes

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510260505

Issue

Hepatology

Hepatology

Volume 26, Issue 5, pages 1115–1122, November 1997

Additional Information

How to Cite

Jalan, R., Forrest, E. H., Stanley, A. J., Redhead, D. N., Forbes, J., Dillon, J. F., MacGilchrist, A. J., Finlayson, N. D. and Hayes, P. C. (1997), A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology, 26: 1115–1122. doi: 10.1002/hep.510260505

Author Information

  1. Department of Medicine, Centre for Liver and Digestive Disorders, Royal Infirmary, Edinburgh, Scotland, UK

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (204K)

References

  • 1
    Pascal JP, Cales P, and Multicentre Study Group Propranolol in the prevention of first upper gastrointestinal tract haemorrhage in patients with cirrhosis of the liver and oesophageal varices. N Engl J Med 1987; 317: 856–861.
  • 2
    Ideo I, Bellati G, Fesce E, Grimoldi D. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective randomised study. Hepatology 1988; 8: 6–9.
    Direct Link:
  • 3
    Lebrec D, Poynard T, Capron JP, Hillon P, Geoffrey P, Roulot D, Chaput JC, et al. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomised trial. J Hepatol 1988; 7: 118–125.
  • 4
    Italian Multicentre Project for Propranolol in the Prevention of Bleeding. Propranolol prevents first gastrointestinal bleed in non-ascitic cirrhotic patients. Final report of a multicentre randomised trial. J Hepatol 1989; 9: 75–83.
  • 5
    Conn HO, Grace ND, Bosch J, Groszmann RJ, Rodes J, Wright SC, Matloff DS, et al. Propranolol in the prevention of the first haemorrhage from oesophagogastric varices. A multicenter randomised clinical trial. Hepatology 1991; 13: 902–912.
    Direct Link:
  • 6
    D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta analytical review. Hepatology 1995; 22: 332–353.
    Direct Link:
  • 7
    Burroughs AK Sclerotherapy of varices. In: RodesJ, ArroyoV. eds. Therapy in Liver Disease. Barcelona: Ediciones Doyma, 1992: 114–127.
  • 8
    Westaby D, MacDougall BRD, Williams R. Improved survival following injection sclerotherapy for oesophageal varices: final analysis of a controlled trial. Hepatology 1985; 5: 627–631.
    Direct Link:
  • 9
    Steigmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, Reveille RM, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992; 326: 1527–1532.
  • 10
    Laine L, El-Newihi HM, Migikovsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 1993; 119: 1–7.
  • 11
    Gimson AES, Ramage JK, Panos MZ, Hayllar K, Harrison PM, Williams R, Westaby D. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet 1993; 342: 391–394.
  • 12
    Lo GH, Lai KH, Cheng JS, Hwu CH, Chang CF, Chang SM, Chiang HU. A prospective, randomised trial of sclerotherapy versus ligation in the management of bleeding oesophageal varices. Hepatology 1995; 22: 466–471.
    Direct Link:
  • 13
    Hou MC, Lin HC, Kuo BIT, Chen CH, Lee FY, Lee SD. Comparison of endoscopic injection sclerotherapy and ligation for the treatment of oesophageal variceal haemorrhage: a prospective randomised trial. Hepatology 1995; 21: 1517–1512.
  • 14
    Hashizume M, Ohta M, Ueno K, Tanoue K, Kitano S, Sugimachi K. Endoscopic ligation of oesophageal varices compared with injection sclerotherapy: a prospective randomised trial. Gatrointest Endoscop 1993; 39: 123–126.
  • 15
    Laine L, Stein C, Sharma V. Randomised comparison of ligation versus ligation plus sclerotherapy in patients with bleeding oesophageal varices. Gastroenterology 1996; 110: 529–533.
  • 16
    Laine L. Ligation: endoscopic treatment of choice for patients with bleeding oesophageal varices. Hepatology 1995; 22: 661–665.
    Direct Link:
  • 17
    La Berge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, et al. Creation of a transjugular intrahepatic portasystemic shunt with Wallstent endoprosthesis: results in 100 patients. Radiology 1993; 187: 413–420.
  • 18
    Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, Berger E, et al. The transjugular intrahepatic stent-shunt procedure for variceal haemorrhage. N Engl J Med 1994; 3: 165–172.
  • 19
    Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johanson K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993; 165: 566–571.
  • 20
    Jalan R, Simpson KJ, Redhead DN, Chalmers N, Hayes PC. Transjugular intrahepatic portosystemic stent shunt (TIPSS): long term follow-up. Q J Med 1994; 87: 565–573.
  • 21
    Jalan R, John TG, Redhead DN, Finlayson NDC, Garden OJ, Hayes PC. A comparative study of the transjugular intrahepatic portosystemic stent-shunt (TIPSS) and oesophageal transection in uncontrolled variceal haemorrhage. Am J Gastroenterol 1995; 11: 1932–1936.
  • 22
    McCormick PA, Dick R, Panagou EB, Chin JKT, Greenslade L, Burroughs AK. Emergency transjugular intrahepatic portosystemic stent-shunt salvage treatment for uncontrolled variceal bleeding. Br J Surg 1994; 81: 1324–1327.
    Direct Link:
  • 23
    Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Cole PA. Transjugular intrahepatic portosystemic stent-shunts for patients with active variceal haemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111: 138–146.
  • 24
    de Franchis R, Pascal J, Ancona E, Burroughs AK, Henderson M, Fleig W, Groszmann R, et al. Definitions and therapeutic strategies in portal hypertension. J Hepatol 1992; 15: 256–261.
  • 25
    Parsons-Smith BC, Sumerskill WHJ, Dawson AM. The electroencephalograph in liver disease. Lancet 1957; 2: 867–871.
  • 26
    Hauenstein KH, Haag K, Ochs A, Langer M, Rossle M. The reducing stent: treatment for transjugular intrahepatic portosystemic stent-shunt induced refractory hepatic encephalopathy and liver failure. Radiology 1995; 194: 175–179.
  • 27
    Graham DY, Smith JL. The course of patients after variceal haemorrhage. Gastroenterology 1981; 80: 800–809.
  • 28
    Lebrec D, Poynard T, Bernuau J, Bercoff J, Nouel O, Capron JP, Poupon R, et al. A randomised controlled study of propranolol for the prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355–358.
    Direct Link:
  • 29
    Burroughs AK, Jenkins WJ, Sherlock S, Dunk A, Walt RP, Osuafor TO, Mackie S, et al. Controlled trial of propranolol for the prevention of variceal haemorrhage in patients with cirrhosis. N Engl J Med 1983; 309: 1539–1542.
  • 30
    Villeneuve JP, Pomier-Layrargeus G, Infante-Rivard C, Willems B, Huet PM, Marleau D, Viallet A. Propranolol for the prevention of recurrent variceal haemorrhage: a controlled trial. Hepatology 1986; 6: 1239–1243.
    Direct Link:
  • 31
    Quieniet AM, Czernichow P, Lerebours E. Etude controlee du propranolol dans la prevention des recidives hemorrhagiques chez le patients cirrhotiques. Gastroenterol Clin Biol 1987; 11: 41–47.
  • 32
    Colombo M, DeFranchis R, Tommasini M, Sangiovanni A, Dioguardi N. Beta blockade prevents recurrent gastrointestinal bleeding in well compensated patients with alcoholic cirrhosis: a multicenter randomised controlled trial. Hepatology 1989; 9: 433–438.
    Direct Link:
  • 33
    Garden OJ, Mills PR, Birnie GG, Murray GD, Carter DC. Propranolol in the prevention of recurrent variceal haemorrhage in cirrhotic patients. A controlled trial. Gastroenterology 1990; 98: 185–190.
  • 34
    Cabrera J, Maynar M. Granados R, Gorriz E, Reyes R, Pulido-Duque JM, Sanroman JLR, et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus sclerotherapy in the elective treatment of variceal haemorrhage. Gastroenterology 1996; 110: 832–839.
  • 35
    Sanyal AJ, Freedman AM, Purdum PP, Luketic VA, Shiffman ML, Tisnado J, Cole P. Transjugular intrahepatic portosystemic shunt vs sclerotherapy for prevention of recurrent variceal haemorrhage: a randomised prospective trial [Abstract]. Gastroenterology 1994; 106: A975.
  • 36
    Merli M, Riggio O, Capocaccia L, Ziparo V, Bolognese A, Rossi P, Salerno F, et al. Transjugular intrahepatic portosystemic shunt (TIPS) vs endoscopic sclerotherapy in preventing variceal rebleeding. Preliminary results of a randomised controlled trial [Abstract]. Hepatology 1994; 20: 107A.
  • 37
    Rossle M, Diebert P, Haag K, Ochs A, Siegerstetter V, Langer M. TIPS vs sclerotherapy and beta-blockade: preliminary results of a randomised study in patients with recurrent variceal haemorrhage [Abstract]. Hepatology 1994; 20: 107A.
  • 38
    Cello JP, Ring EJ, Olcott E, Koch J, Gordon R, Sandhu F, Ostroff J, et al. Transjugular intrahepatic portosystemic shunt (TIPS) vs sclerotherapy (ES) for variceal haemorrhage (VH) [Abstract]. Gastroenterology 1995; 108: A1045.
  • 39
    Sauer P, Theilmann L, Roeren T, Richter G, Stremmel W, Sttiehl A. Transjugular intrahepatic portosystemic stent shunt (TIPS) vs sclerotherapy in the prevention of variceal rebleeding: a randomised study [Abstract]. Gastroenterology 1996; 110: A1313.
  • 40
    Groupe d'Etude des Anastomoses Intra-Hepatiques (Toulouse, Bondy, Lille, Nice, Creteil, Paris) France. TIPS vs sclerotherapy + propranolol in the prevention of variceal rebleeding: preliminary results of a multicenter randomised trial [Abstract]. Hepatology 1995; 22: 299A.
  • 41
    Garcia-Villareal L, Martinez-Lagares F, Sierra A, Guevara C, Hernandez-Cabrero T, Marrero JM, Jimenez E, et al. TIPS vs sclerotherapy for the prevention of variceal rebleeding. Preliminary results of a randomised study [Abstract]. Hepatology 1996; 24: 208A.
  • 42
    Silva G, Fluxa F, Bresky G, Backhouse C, Palma M, Ruiz M, Hirsch S, et al. Splanchnic and systemic haemodynamics in early abstinence and after ethanol administration in non-cirrhotic alcoholic patients. J Hepatol 1994; 20: 494–499.
  • 43
    Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP III, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20: 46–55.
  • 44
    Jalan R, Elton RA, Redhead DN, Simpson KJ, Finlayson NDC, Hayes PC. Analysis of prognostic variables in the prediction of shunt failure, variceal rebleeding, early mortality and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt (TIPSS). J Hepatol 1995; 23: 123–128.
  • 45
    Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastro-oesophageal varices and variceal bleeding. Hepatology 1985; 5: 419–424.
    Direct Link:
  • 46
    Jalan R, Redhead DN, Forrest EH, Hayes PC. Relationship between directly measured portal pressure and variceal haemorrhage. Am J Gastroenterol 1995; 90: 1994–1996.
  • 47
    LaBerge JM, Ferrell LD, Ring, EJ, Gordon RL. Histopathological study of stenotic and occluded transjugular intrahepatic portosystemic shunt. J Vasc Intervent Radiol 1993; 4: 779–786.
  • 48
    Jalan R, Harrison DJ, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt and the role of biliary venous fistula. J Hepatol 1996; 24: 169–176.
  • 49
    Ferguson J, Jalan R, Redhead DN, Hayes P, Allan PA. The role of Duplex Doppler in monitoring shunt function following transjugular intrahepatic stent shunt. Br J Radiol 1995; 68: 587–589.
Get PDF (204K)